Creative Selling General Administrative from 2010 to 2025

CELZ Stock  USD 4.97  0.08  1.58%   
Creative Medical Selling General Administrative yearly trend continues to be fairly stable with very little volatility. Selling General Administrative is likely to outpace its year average in 2025. During the period from 2010 to 2025, Creative Medical Selling General Administrative regression line of annual values had r-squared of  0.85 and arithmetic mean of  1,392,947. View All Fundamentals
 
Selling General Administrative  
First Reported
2007-09-30
Previous Quarter
676.1 K
Current Value
498.6 K
Quarterly Volatility
356.4 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.7 M, Other Operating Expenses of 6.8 M or Total Operating Expenses of 6.8 M, as well as many indicators such as Price To Sales Ratio of 681, Dividend Yield of 0.0039 or PTB Ratio of 0.76. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
  
Check out the analysis of Creative Medical Correlation against competitors.

Latest Creative Medical's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Creative Medical Technology over the last few years. It is Creative Medical's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Creative Selling General Administrative Regression Statistics

Arithmetic Mean1,392,947
Geometric Mean285,558
Coefficient Of Variation107.96
Mean Deviation1,277,658
Median1,050,485
Standard Deviation1,503,854
Sample Variance2.3T
Range3.9M
R-Value0.92
Mean Square Error367.4B
R-Squared0.85
Slope290,939
Total Sum of Squares33.9T

Creative Selling General Administrative History

20253.7 M
20243.5 M
20233.1 M
20223.9 M
2021M
20201.2 M
20191.2 M

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's Selling General Administrative, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative3.5 M3.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.